Tugba Tastemel Ozturk1, Nur Canpolat2, Seha Saygili2, Umut Selda Bayrakci3, Oguz Soylemezoglu4, Fatih Ozaltin5,6, Rezan Topaloglu5. 1. Department of Pediatric Nephrology, Faculty of Medicine, Hacettepe University, Sihhiye, 06100, Ankara, Turkey. t_tastemel@hotmail.com. 2. Department of Pediatric Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. 3. Department of Pediatric Nephrology, Faculty of Medicine, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey. 4. Department of Pediatric Nephrology, Faculty of Medicine, Gazi University, Ankara, Turkey. 5. Department of Pediatric Nephrology, Faculty of Medicine, Hacettepe University, Sihhiye, 06100, Ankara, Turkey. 6. Nephrogenetics Laboratory, Department of Pediatric Nephrology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Abstract
BACKGROUND: Recently, recessive mutations in SGPL1 (sphingosine-1-phosphate lyase), which encodes the final enzyme of sphingolipid metabolism, have been reported to cause steroid-resistant nephrotic syndrome, adrenal insufficiency, and many other organ/system involvements. We aimed to determine the clinical and genetic characteristics, and outcomes in patients with SGPL1 mutations. METHODS: The study included 6 patients with bi-allelic SGPL1 mutation. Clinical, genetic, and laboratory characteristics, and outcomes of the patients were evaluated retrospectively. We also reviewed previously reported patients with SGPL1 mutations and compared them to the presented patients. RESULTS: The median age at kidney presentation was 5 months. Four patients (67%) were diagnosed before age 1 year. Kidney biopsy showed focal segmental glomerulosclerosis in 2 patients and diffuse mesangial sclerosis in one patient. Steroids were given to 3 patients, but they did not respond. All 6 patients progressed to chronic kidney disease; 5 required kidney replacement therapy (KRT) at a median age of 6 months. Deceased kidney transplantation was performed in one patient. All 6 patients had adrenal insufficiency, of which 5 were diagnosed at age < 6 months. Three patients had hypothyroidism, 2 had ichthyosis, 4 had immunodeficiency, 5 had neurological findings, and 2 had genitourinary system anomalies. Four patients died at a median age of 30.5 months. Two patients are being followed up with KRT. One patient had a novel mutation. CONCLUSIONS: Patients with SGPL1 mutations have a poor prognosis, and many types of extrarenal organ/system involvement beyond adrenal insufficiency can be seen. Genetic diagnosis of such patients is important for treatment, genetic counseling, and screening for comorbid conditions. A higher resolution version of the Graphical abstract is available as Supplementary information.
BACKGROUND: Recently, recessive mutations in SGPL1 (sphingosine-1-phosphate lyase), which encodes the final enzyme of sphingolipid metabolism, have been reported to cause steroid-resistant nephrotic syndrome, adrenal insufficiency, and many other organ/system involvements. We aimed to determine the clinical and genetic characteristics, and outcomes in patients with SGPL1 mutations. METHODS: The study included 6 patients with bi-allelic SGPL1 mutation. Clinical, genetic, and laboratory characteristics, and outcomes of the patients were evaluated retrospectively. We also reviewed previously reported patients with SGPL1 mutations and compared them to the presented patients. RESULTS: The median age at kidney presentation was 5 months. Four patients (67%) were diagnosed before age 1 year. Kidney biopsy showed focal segmental glomerulosclerosis in 2 patients and diffuse mesangial sclerosis in one patient. Steroids were given to 3 patients, but they did not respond. All 6 patients progressed to chronic kidney disease; 5 required kidney replacement therapy (KRT) at a median age of 6 months. Deceased kidney transplantation was performed in one patient. All 6 patients had adrenal insufficiency, of which 5 were diagnosed at age < 6 months. Three patients had hypothyroidism, 2 had ichthyosis, 4 had immunodeficiency, 5 had neurological findings, and 2 had genitourinary system anomalies. Four patients died at a median age of 30.5 months. Two patients are being followed up with KRT. One patient had a novel mutation. CONCLUSIONS: Patients with SGPL1 mutations have a poor prognosis, and many types of extrarenal organ/system involvement beyond adrenal insufficiency can be seen. Genetic diagnosis of such patients is important for treatment, genetic counseling, and screening for comorbid conditions. A higher resolution version of the Graphical abstract is available as Supplementary information.
Authors: Andreas R Janecke; Ruijuan Xu; Elisabeth Steichen-Gersdorf; Siegfried Waldegger; Andreas Entenmann; Thomas Giner; Iris Krainer; Lukas A Huber; Michael W Hess; Yaacov Frishberg; Hila Barash; Shay Tzur; Nira Schreyer-Shafir; Rivka Sukenik-Halevy; Tania Zehavi; Annick Raas-Rothschild; Cungui Mao; Thomas Müller Journal: Hum Mutat Date: 2017-03-06 Impact factor: 4.878
Authors: Jillian K Warejko; Weizhen Tan; Ankana Daga; David Schapiro; Jennifer A Lawson; Shirlee Shril; Svjetlana Lovric; Shazia Ashraf; Jia Rao; Tobias Hermle; Tilman Jobst-Schwan; Eugen Widmeier; Amar J Majmundar; Ronen Schneider; Heon Yung Gee; J Magdalena Schmidt; Asaf Vivante; Amelie T van der Ven; Hadas Ityel; Jing Chen; Carolin E Sadowski; Stefan Kohl; Werner L Pabst; Makiko Nakayama; Michael J G Somers; Nancy M Rodig; Ghaleb Daouk; Michelle Baum; Deborah R Stein; Michael A Ferguson; Avram Z Traum; Neveen A Soliman; Jameela A Kari; Sherif El Desoky; Hanan Fathy; Martin Zenker; Sevcan A Bakkaloglu; Dominik Müller; Aytul Noyan; Fatih Ozaltin; Melissa A Cadnapaphornchai; Seema Hashmi; Jeffrey Hopcian; Jeffrey B Kopp; Nadine Benador; Detlef Bockenhauer; Radovan Bogdanovic; Nataša Stajić; Gil Chernin; Robert Ettenger; Henry Fehrenbach; Markus Kemper; Reyner Loza Munarriz; Ludmila Podracka; Rainer Büscher; Erkin Serdaroglu; Velibor Tasic; Shrikant Mane; Richard P Lifton; Daniela A Braun; Friedhelm Hildebrandt Journal: Clin J Am Soc Nephrol Date: 2017-11-10 Impact factor: 8.237
Authors: Svjetlana Lovric; Sara Goncalves; Heon Yung Gee; Babak Oskouian; Honnappa Srinivas; Won-Il Choi; Shirlee Shril; Shazia Ashraf; Weizhen Tan; Jia Rao; Merlin Airik; David Schapiro; Daniela A Braun; Carolin E Sadowski; Eugen Widmeier; Tilman Jobst-Schwan; Johanna Magdalena Schmidt; Vladimir Girik; Guido Capitani; Jung H Suh; Noëlle Lachaussée; Christelle Arrondel; Julie Patat; Olivier Gribouval; Monica Furlano; Olivia Boyer; Alain Schmitt; Vincent Vuiblet; Seema Hashmi; Rainer Wilcken; Francois P Bernier; A Micheil Innes; Jillian S Parboosingh; Ryan E Lamont; Julian P Midgley; Nicola Wright; Jacek Majewski; Martin Zenker; Franz Schaefer; Navina Kuss; Johann Greil; Thomas Giese; Klaus Schwarz; Vilain Catheline; Denny Schanze; Ingolf Franke; Yves Sznajer; Anne S Truant; Brigitte Adams; Julie Désir; Ronald Biemann; York Pei; Elisabet Ars; Nuria Lloberas; Alvaro Madrid; Vikas R Dharnidharka; Anne M Connolly; Marcia C Willing; Megan A Cooper; Richard P Lifton; Matias Simons; Howard Riezman; Corinne Antignac; Julie D Saba; Friedhelm Hildebrandt Journal: J Clin Invest Date: 2017-02-06 Impact factor: 14.808